Lars Møller Pedersen

13PUBLICATIONS
28CO-AUTHORS
Haematological tumoursPredictive and prognostic markersLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Medical microbiology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 09, 2026
Second primary cancers in lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia-cumulative burden without generalized excess cancer risk.

|Dec 05, 2025
Time to Next Treatment Within 24 Months (TTNT24) as a Predictor of Survival in Lymphoplasmacytic Lymphoma/Waldenström Macroglobulinemia: A Population-Based Observational Study.

Lars Munksgaard, Lars Moeller Pedersen, Amalie Sofie Eilsoe Munksgaard

|Oct 11, 2025
Core Needle Biopsies in Patients With Lymphoproliferative Malignancies: An Observational Single-Center Cohort Study.

Blas Holger Mogensen, Torsten Holm Nielsen, Mette Ølgod Pedersen

|Aug 29, 2025
Real-World Safety and Efficacy of Venetoclax in Chronic Lymphocytic Leukemia: A Single-Center Comparative Analysis With Randomized Clinical Trials.

Sophie Thau, Christian Bjørn Poulsen, Morten Kranker Larsen

|Jan 09, 2025
Impact of Trial Eligibility Criteria on Outcomes of 1183 Patients With Follicular Lymphoma Treated in the Real-World Setting.

Tine Litske Bennedsen, Mikkel Runason Simonsen, Paw Jensen

|Jan 06, 2025
Limited Benefit of Routine Clinical Follow-Up for Relapse Detection in Diffuse Large B-Cell Lymphoma Patients in Complete Remission Following First-Line Treatment.

Therese Lassen, Torsten H Nielsen, Annika von Heymann

Pageof 3

Frequent Collaborators

3 joint publications

Lise Mette Rahbek Gjerdrum

2 joint publications

Lars Munksgaard

2 joint publications

Marie Fredslund Breinholt

2 joint publications

Anne Ortved Gang